BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 12142609)

  • 1. S100-positive spindle cells in scars: a diagnostic pitfall in the re-excision of desmoplastic melanoma.
    Chorny JA; Barr RJ
    Am J Dermatopathol; 2002 Aug; 24(4):309-12. PubMed ID: 12142609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. S100 expression in cutaneous scars: a potential diagnostic pitfall in the diagnosis of desmoplastic melanoma.
    Robson A; Allen P; Hollowood K
    Histopathology; 2001 Feb; 38(2):135-40. PubMed ID: 11207826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atypical cells in human cutaneous re-excision scars for melanoma express p75NGFR, C56/N-CAM and GAP-43: evidence of early Schwann cell differentiation.
    Trejo O; Reed JA; Prieto VG
    J Cutan Pathol; 2002 Aug; 29(7):397-406. PubMed ID: 12139634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SOX-10 staining in dermal scars.
    Behrens EL; Boothe W; D'Silva N; Walterscheid B; Watkins P; Tarbox M
    J Cutan Pathol; 2019 Aug; 46(8):579-585. PubMed ID: 30950082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p75 nerve growth factor receptor staining helps identify desmoplastic and neurotropic melanoma.
    Kanik AB; Yaar M; Bhawan J
    J Cutan Pathol; 1996 Jun; 23(3):205-10. PubMed ID: 8793654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histologic differentiation of desmoplastic melanoma from cicatrices.
    Kaneishi NK; Cockerell CJ
    Am J Dermatopathol; 1998 Apr; 20(2):128-34. PubMed ID: 9557779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SOX10 immunostaining distinguishes desmoplastic melanoma from excision scar.
    Ramos-Herberth FI; Karamchandani J; Kim J; Dadras SS
    J Cutan Pathol; 2010 Sep; 37(9):944-52. PubMed ID: 20653825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of Melan-A and Ki-67 in desmoplastic melanoma and desmoplastic nevi.
    Kucher C; Zhang PJ; Pasha T; Elenitsas R; Wu H; Ming ME; Elder DE; Xu X
    Am J Dermatopathol; 2004 Dec; 26(6):452-7. PubMed ID: 15618925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Normal Expression of SRY-related HMG-BOX Gene 10 (SOX-10) in Recent and Old Cutaneous Scars is a Potential Mimicker of Desmoplastic Malignant Melanoma.
    Febres-Aldana CA; Alexis J
    Appl Immunohistochem Mol Morphol; 2020 Mar; 28(3):197-204. PubMed ID: 30672775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. P75 nerve growth factor receptor staining is superior to S100 in identifying spindle cell and desmoplastic melanoma.
    Lazova R; Tantcheva-Poor I; Sigal AC
    J Am Acad Dermatol; 2010 Nov; 63(5):852-8. PubMed ID: 20950740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microphthalmia transcription factor and melanoma cell adhesion molecule expression distinguish desmoplastic/spindle cell melanoma from morphologic mimics.
    Koch MB; Shih IM; Weiss SW; Folpe AL
    Am J Surg Pathol; 2001 Jan; 25(1):58-64. PubMed ID: 11145252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Procollagen 1 and Melan-A expression in desmoplastic melanomas.
    Leinweber B; Hofmann-Wellenhof R; Kaddu S; McCalmont TH
    Am J Dermatopathol; 2009 Apr; 31(2):173-6. PubMed ID: 19318805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NGFR (p75) expression in cutaneous scars; Further evidence for a potential pitfall in evaluation of reexcision scars of cutaneous neoplasms, in particular desmoplastic melanoma.
    Otaibi S; Jukic DM; Drogowski L; Bhawan J; Radfar A
    Am J Dermatopathol; 2011 Feb; 33(1):65-71. PubMed ID: 21178583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NGFR-positive desmoplastic melanomas with focal or absent S-100 staining: Further evidence supporting the use of both NGFR and S-100 as a primary immunohistochemical panel for the diagnosis of desmoplastic melanomas.
    Radfar A; Stefanato CM; Ghosn S; Bhawan J
    Am J Dermatopathol; 2006 Apr; 28(2):162-7. PubMed ID: 16625082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Melanotic pigmentation in excision scars of melanocytic and non-melanocytic skin tumors.
    Botella-Estrada R; Sanmartín O; Sevila A; Escudero A; Guillén C
    J Cutan Pathol; 1999 Mar; 26(3):137-44. PubMed ID: 10235379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Desmoplastic malignant melanoma. An immunocytochemical study of 25 cases.
    Anstey A; Cerio R; Ramnarain N; Orchard G; Smith N; Jones EW
    Am J Dermatopathol; 1994 Feb; 16(1):14-22. PubMed ID: 7512798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutaneous desmoplastic melanoma.
    Busam KJ
    Adv Anat Pathol; 2005 Mar; 12(2):92-102. PubMed ID: 15731577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HMB-45 recognizes stimulated melanocytes.
    Smoller BR; McNutt NS; Hsu A
    J Cutan Pathol; 1989 Apr; 16(2):49-53. PubMed ID: 2668355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Re-excisions of scar in primary cutaneous melanoma: a histopathological study.
    Fallowfield ME; Cook MG
    Br J Dermatol; 1992 Jan; 126(1):47-51. PubMed ID: 1536761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of immunohistochemical staining of the novel antibody melan-A with S100 protein and HMB-45 in malignant melanoma and melanoma variants.
    Blessing K; Sanders DS; Grant JJ
    Histopathology; 1998 Feb; 32(2):139-46. PubMed ID: 9543670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.